ArloJMillerMDPhD

PubMed

• 116 citations
  Sumoylation of MITF and its related family members TFE3 and TFEB.
  Arlo J. Miller, Carmit Levy, Ian J. Davis, Ehud Razin, David E. Fisher
  The Journal of Biological Chemistry. 2005-01-07
• 88 citations
  Malignant melanoma in the 21st century: the emerging molecular landscape.
  Aleksandar Sekulic, Paul Haluska, Arlo J. Miller, Josep Genebriera De Lamo, Samuel Ejadi
  Mayo Clinic Proceedings. 2008-07-01
• 74 citations
  Epistatic connections between microphthalmia-associated transcription factor and endothelin signaling in Waardenburg syndrome and other pigmentary disorders
  Kayo Sato-Jin, Emi K. Nishimura, Eijiro Akasaka, Wade E. Huber, Hajime Nakano
  FASEB Journal. 2008-04-01

Journal Articles

• The Molecular Basis of Melanomagenesis and the Metastatic Phenotype.  
  Crowson AN, Magro C, Miller A, Mihm MC Jr, Seminars in Oncology
• Epistatic Connections between MITF and Endothelin Signaling in Waardenburg Syndrome and Other Pigmentary Disorders.  
  Sato-Jin K, Nishimura EK, Akasaka E, Huber W, Nakano H, Miller A, Du J, Wu M, Hanada K, Sawamura D, Fisher DE, and Imokawa G, EMBO
• New insights into pigmentary pathways and skin cancer.  
  Miller AJ, Tsao H, British Journal of Dermatology
• Malignant Melanoma in the 21st Century, Part 3: The Emerging Molecular Landscape.  
  Sekulic A, Haluska P Jr, Miller AJ, Genebriera De Lamo J, Ejadi S, Pulido JS, Salomao DR, Thorland EC, Vile RG, Swanson DL, Pockaj BA, Laman SD, Pittelkow MR, Markovic..., Mayo Clinic Proceedings. 2008 Jul;83(7):825-46
• Join now to see all

Abstracts/Posters

• High definition clonal analysis of human melanoma.
  A Sekulic, A Miller, M Barrett, A Mengos, M Pittelkow, Society of Investigative Dermatology, Montreal
• Identification of targetable cellular subsets within melanoma tumors.
  A. Sekulic, A. Miller, M. Barrett, S. Ejadi, A. Mengos, B. Pockaj, S. Markovic, American Society of Clinical Oncology, Orlando
• Personalized approach to analysis of melanoma tumor heterogeneity with potential implications for therapy.
  A. Miller, M. Barrett, A. Mengos, M. Pittelkow, A. Sekulic, American Academy of Dermatology, Boston